Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.
| Autor: | Caliskan AR; Department of Gastroenterology, Adiyaman Training and Research Hospital, Adiyaman, Turkiye., Muhip Harputluoglu MM; Department of Gastroenterology, Inonu University School of Medicine, Malatya, Turkiye., Samdanci E; Department of Pathology, Inonu University School of Medicine, Malatya, Turkiye., Cirik S; Department of Internal Medicine, Malatya Training and Research Hospital, Malatya, Turkiye., Yilmaz S; Department of General Surgery, Liver Transplantation Institute, Inonu University School of Medicine, Malatya, Turkiye. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Hepatology forum [Hepatol Forum] 2023 May 18; Vol. 4 (2), pp. 74-77. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023). |
| DOI: | 10.14744/hf.2022.2022.0033 |
| Abstrakt: | Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis. Competing Interests: The authors have no conflict of interest to declare. (© Copyright 2023 by Hepatology Forum.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|